McGill Summer Institute in Infectious Diseases and Global Health

Composite: Scientist in lab coat, hands hold white paper dove, physiotherapy patient, crowd from above

Proudly offering short courses for students and professionals for eight years.

2023 boasts 15 courses (our most ever!) -- all taught by McGill professors and internationally known guest speakers. All courses for 2023 are available online and we are offering 6 courses in-person this year for those that want to join us in beautiful Montreal. Courses are taught by leaders in the field of infectious diseases at McGill University and the McGill University Health Centre. Topics include TB, HIV, AIDS, tropical diseases, and COVID-19. In addition, we bring a wide variety of guest faculty from all over the world to give their unique perspective. Learn more at the Summer Institute website.


Gloved hand holding petridishAntimicrobial Resistance (AMR) | June 8-10, 2023

Register before May 5th to receive the discount:

  • In-person attendance use code “AMR50QC” for 50% off registration fee
  • Online attendance use code “AMR20QC” for 20% off registration fee
    (discounts only valid for those living, working or studying in Quebec)

Scholarships also available-deadline April 24th

Scholarships for graduate students and residents are also available to cover registration fees for the course. To read more about eligibility criteria apply please visit our application form. Deadline to apply is April 24th and winners will be informed by May 1st.



Hybrid. Course will be live to both the in-person and online participants approximately 9:00am-4:00pm (Montreal time) each day June 8-10, 2023. Live content will be recorded.


The focus of this three-day course is on understanding the complex causes underlying the emergence and spread of AMR, on identifying practical approaches to tackle antibiotic misuse in different settings, and discussing promising scientific advances related to AMR.


Makeda Semret, MSc, MD, FRCPC

Associate Professor of Medicine, Infectious Diseases and Medical Microbiology, McGill University
Lead, Antimicrobial Stewardship Program, MUHC
Director, Training Program in Infectious Diseases and Medical Microbiology, McGill University
Associate Director, McGill AMR Centre
Read Dr. Semret's recent Lancet Infectious Diseases profile

Erika Vlieghe MD
Head of the Department of General Internal Medicine, Infectious Diseases and Tropical Medicine, University Hospital Antwerp
Professor of Infectious Diseases, University of Antwerp

Dao Nguyen, MSc, MD, FRCPC
Associate Professor of Medicine, Microbiology and Immunology, McGill University
Founder and Director, McGill AMR Centre


  • Alemseged Abdissa -Armauer Hansen Research Institute, Ethiopia
  • Annelie Monnier – Radboud University Medical Center, the Netherlands.
  • Bastien Castagner – McGill University, Canada
  • Cedric Yansouni – McGill University, Canada
  • Christian Lavallee -Université de Montréal, Canada
  • Corinne Maurice – McGill University, Canada
  • Daniel de Vos - Queen Astrid Military Hospital, Belgium
  • Dao Nguyen – McGill University, Canada
  • Erika Vlieghe – University Hospital Antwerp, Belgium
  • Heiman Wertheim – Radboud University, Netherlands
  • Ian Marr – Menzies School of Health Research, Australia
  • Iruka Okeke – Nigerian Academy of Sciences, Nigeria
  • Janne Vehreschild – German Centre for Infection Research (DZIF), Germany
  • Jen Ronholm – McGill University, Canada
  • Jesse Shapiro – McGill University, Canada
  • Louis Valiquette – Université de Sherbrooke, Canada
  • Louis-Patrick Haraoui – Université de Sherbrooke, Canada
  • Makeda Semret – McGill University, Canada
  • Marcus Zervos – Henry Ford Health System, USA
  • Pem Chuki – Khesar Gyalpo University of Medical Science, Bhutan
  • Raffaella Ravinetto – Institute of Tropical Medicine Antwerp, Belgium
  • Sam Gruenheid – McGill University, Canada
  • Senjuthi Saha- Child Health Research Foundation, Bangladesh
  • Stephane Bayen – McGill University, Canada
  • Tessa Wyllie -Menzies School of Health Research, Timor Leste and Australia
  • Tinsae Alemayehu -American Medical Center and St Paul Millennial Medical Hospital, Ethiopia
  • Yves Longtin – McGill University, Canada

Faculty are still being confirmed and there may be changes to the above list.


Antimicrobial resistance (AMR) is now one the biggest threats facing modern medicine. Initially described mostly in association with hospital-associated infections in high-income countries, the highest rates of AMR are now reported from low and middle-income countries (LMIC) around the world. The causes underlying the global rise in AMR are complex, but central to this crisis is overconsumption of antibiotics.

This 3-day hybrid course will focus on understanding the complex causes underlying the emergence and spread of AMR, on approaches to tackle antibiotic misuse in different settings, and on discussing promising scientific advances related to AMR.

The course format is a mix of plenary talks and panel discussions, with opportunities to interact with course faculty and participants who work across the spectrum of the antimicrobial resistance space indifferent countries.

Clinicians, researchers, implementers, and health educators from both high-income and low and middle-income countries will share questions, successes, and lessons learned to advance the field of AMR.


At the end of this course, participants will be able to:

  • Understand the basic mechanisms and trends in antimicrobial resistance
  • Describe essential diagnostic tools and challenges/opportunities for improved AMR surveillance in different settings
  • Identify adaptive challenges and practical solutions to implementing stewardship programs in different settings
  • Understand the emerging issues in antimicrobial use and resistance in agriculture and natural environments, and their potential link to human health
  • Discuss promising advances in AMR-related biomedical research


This course appeals to a wide range of participants including:

  • Clinicians, pharmacists, technologists, researchers and students studying infectious diseases, tropical medicine, or global health
  • Policy makers and public health agency officials
  • Product developers and funders
  • Community advocacy groups working in global health


In-person maximum 150 participants.

Online maximum 100 participants.





Back to top